News

A functional brain imaging study led by scientists at the Amen Clinics in Newport Beach, California, has qualified differences between women’s and men’s brains with relevant findings for Alzheimer’s disease research. The study, “Gender-Based Cerebral Perfusion Differences in 46,034 Functional Neuroimaging Scans,” appeared in the Journal of Alzheimer’s Disease. Understanding…

A research team from MIT has found a way to reverse memory loss in mice, which may lead to new treatments for patients with Alzheimer’s disease. The findings were reported in a study titled “The Transcription Factor Sp3 Cooperates with HDAC2 to Regulate Synaptic Function and Plasticity in Neurons”…

Loyola Medicine will participate in a landmark $100 million study called “Imaging Dementia – Evidence for Amyloid Scanning (IDEAS)” to evaluate the effectiveness of using positron emission tomography (PET) scans to detect Alzheimer’s disease (AD). The IDEAS (NCT02420756)…

The use of antidepressants in patients with Alzheimer’s disease increased their risk of head injuries, a Finnish study recently found. The risk of head injuries in these patients previously had not been studied. Head injuries are often a consequence of falls in older people.

A student-led team of researchers at Washington University School of Medicine (WUSM) in St. Louis, Missouri, has developed an online app designed to streamline the process of Alzheimer’s disease diagnosis. It provides physicians with more information about patients before they are evaluated in person, enabling physicians to assess and assist patients…

VTv Therapeutics has received another U.S. patent for azeliragon, an Alzheimer’s treatment that targets a receptor involved in the disease’s inflammation. Azekuragan is an antagonist of the advanced glycation endproducts, or RAGE, receptor, meaning that it prevents the receptor from acting. Found in low levels in a healthy brain, RAGE…

The National Institutes of Health has awarded the University of California at Davis a multiyear grant of nearly $14.7 million to pinpoint the reasons why Latinos have higher rates of dementia than other American ethnic groups. Nine other universities will take part in the UC Davis-led study. Researchers will…

The physical properties of proteins in the spinal fluid and blood of people with Alzheimer’s disease may constitute valuable biomarkers to help diagnose disease progression and predict patients’ outcomes, new research from The Ohio State University suggests. The biomarkers may help researchers develop better treatments in the future, especially for later stages of…

Patients with Alzheimer’s disease may have more bacteria — and different types — in their brains, compared to the general population, according to results of a new study. These findings support that bacterial infection and inflammation may contribute to the development of this devastating disease. The study is titled “…

Pain Therapeutics will soon launch a Phase 1 clinical trial to study the safety and efficacy of PTI-125 in treating Alzheimer’s disease. The announcement came after the U.S. Food and Drug Administration (FDA) accepted the company’s investigational new drug application for the therapy. It follows a recently awarded $1.7 million research grant by the…